Clinical Trial Update: Bone Loss in Men on Androgen Blockade as Adjuvant Therapy for Prostate Cancer

View source ↗

Summary

A completed clinical trial update addressing bone loss in men receiving androgen blockade as adjuvant therapy for prostate cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bone Loss
• Prostate Cancer

Snippet

Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | Conditions: Prostate Cancer, Bone Loss | Status: COMPLETED